Home / Sources / Select Committees / Public Accounts Committee / Antimicrobial resistance: addressing th…
Index live · Last sync 23 May 2026
Select Committee · Public Accounts Committee

Antimicrobial resistance: addressing the risks

Status: Closed Opened: 15 Jan 2025 Closed: 21 Aug 2025 18 recommendations 28 conclusions 1 report

Antimicrobial-resistant (AMR) infections cause an estimated 1.3m deaths globally each year, and rising, and lead to the failure of antibiotics for treating human illness. 67,000 people experienced an AMR infection in 2023. 2,200 of those people died. The UN has predicted that by 2050, AMR will cause 10m or more deaths, comparable to cancer as …

Clear

Reports

1 report
Title HC No. Published Items Response
30th Report - Antimicrobial resistance: addressing the risks HC 646 13 Jun 2025 46 Responded

Recommendations & Conclusions

1 item
11 Conclusion 30th Report - Antimicrobial resistance:… Not Addressed

Cuts to ODA funding threaten UK's global AMR efforts and Fleming Fund initiatives

An important part of the UK’s international work on AMR is the aid provided, particularly through the Fleming Fund, to fund AMR initiatives in low- and middle-income countries. This aid can help support the global fight against AMR, for example by helping to develop surveillance and data collection for AMR …

Government response. The government states the recommendation is "implemented" and outlines how AMR is addressed in the National Action Plan and trade agreements, but does not address the committee's specific concern regarding the impact of UK aid cuts on international AMR efforts.
HM Treasury

Oral evidence sessions

1 session
Date Witnesses
27 Mar 2025 Abigail Seager · Defra, Dr David Partridge · Sheffield Teaching Hospitals NHS Trust, Professor Sir Chris Whitty · Department for Health and Social Care, Professor Sir Stephen Powis · NHS England, Professor Susan Hopkins · UK Health Security Agency (UKHSA), The Lord O'Neill of Gatley View ↗